Week in Review: January 13

The Week in Review provides an overview of the past week’s top health care content, including industry news and trends, Mayo Clinic and Mayo Clinic Laboratories news, and upcoming events.

Industry News

With attention to mpox fading, health officials fear infections will go undetected and unreported

Dwindling case counts obscure an important reality: The global footprint of mpox, which until a few years ago could only be contracted in parts of Africa, has expanded substantially. Source: STAT

Read article.

As COVID surges in China, US begins testing more travelers

As of Thursday, the CDC is also requiring travelers to the U.S. from China, Hong Kong and Macao to take a COVID-19 test no more than two days before travel and provide a negative result before boarding a flight. Source: AP

Read article.

FDA approves Alzheimer's drug that appears to modestly slow disease

An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%. Source: NPR

Read article.

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.